For more information or confidential assistance
Call 800-306-3180

Xarelto Bleeding Trial Opens in Philadelphia

A bellwether trial over the risk of bleeding injury with Xarelto (rivaroxoaban) opened in Philadelphia in early November. The trial will hear a case filed by Lynn Hartman and her spouse, alleging that Xarelto’s side effects cause Ms. Hartman to experience severe internal bleeding. Xarelto... Read More

Xarelto Bellwether Trials Begin

In the last week of April, the first bellwether trial involving lawsuits over alleged injuries caused by Xarelto (rivaroxoaban) began with the process of jury selection. The case is one of 16,000 Xarelto lawsuits under a federal multidistrict litigation (MDL) before District Judge Eldon Fallon in the... Read More

Bellwether Cases Chosen in Xarelto MDL

Xarelto packaging
Multidistrict (MDL) litigation established in order to consolidate all federal cases related to Xarelto has now progressed to the point where U.S. District Judge Eldon Fallon has chosen a series of four representative cases which will be heard in early 2017. The purpose of these... Read More

Safety Study for Xarelto Under Question by FDA

Since it first hit the market in 2011, millions of Americans have been prescribed Xarelto, a newer generation of blood-thinning drugs touted as an alternative to warfarin (Coumadin). But recently, healthcare experts have been questioning whether the clinical trial that led to the FDA approval... Read More

Xarelto MDL Bellwether Selection Underway

The process for determining which cases from the Xarelto multidistrict litigation in the Eastern District of Louisiana will be included in a bellwether discovery pool has been determined. U.S. District Judge Eldon Fallon issued a case management order on Nov. 20 outlining the selection criteria.... Read More

Four Plaintiffs File Joint Complaint in Xarelto MDL

Adding to the growing list of lawsuits in the Xarelto federal multidistrict litigation (MDL), a group of four plaintiffs have come together to file a joint complaint alleging that they each suffered serious harm after using Jannsen's anticoagulant drug. The highly detailed complaint outlines the... Read More